Carcinogenic purine N-oxide ester modifies covalently all common bases in polynucleotides

Area of Science:

• Biochemistry
• Molecular Biology
• Toxicology

Background:

• 1-methyl-3-hydroxyxanthine is a known carcinogen.
• Carcinogens can interact with genetic material, leading to mutations and disease.
• Understanding the specific binding mechanisms of carcinogens to nucleic acids is crucial for risk assessment.

Purpose of the Study:

• To investigate the covalent binding of esterified 1-methyl-3-hydroxyxanthine to various polynucleotides, RNA, and DNA.
• To characterize the major adducts formed after enzymatic digestion.
• To determine the extent of DNA modification by this carcinogen.

Main Methods:

• Incubation of 1-methyl-3-hydroxyxanthine with different polynucleotides (poly(A), poly(U), poly(dT), poly(G), poly(C)), RNA, and DNA.
• Enzymatic digestion of modified nucleic acids.
• Characterization of nucleoside adducts using analytical techniques.

Main Results:

• Esterified 1-methyl-3-hydroxyxanthine covalently binds to all tested ribopolynucleotides and poly(dT).
• Covalent binding efficiency varies, with poly(A) showing the highest modification.
• Maximal modification of DNA was observed at one moiety per 360 nucleotides.
• Major adducts were characterized as nucleosides for most modified polynucleotides, RNA, and DNA.

Conclusions:

• 1-methyl-3-hydroxyxanthine readily modifies nucleic acids, forming covalent adducts.
• The study elucidates the binding preferences and extent of modification of this carcinogen to genetic material.
• Characterization of nucleoside adducts provides insights into potential genotoxic mechanisms.